Global Coagulation Factor XI Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Coagulation Factor XI Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Coagulation Factor XI report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Coagulation Factor XI market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Thrombosis and Bleeding and Clotting Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Coagulation Factor XI industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Coagulation Factor XI key companies include Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc. and LegoChem Biosciences, Inc, etc. Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC are top 3 players and held % share in total in 2022.
Coagulation Factor XI can be divided into MR-1007, IONIS-FXIRx, EP-7041 and AB-022, etc. MR-1007 is the mainstream product in the market, accounting for % share globally in 2022.
Coagulation Factor XI is widely used in various fields, such as Thrombosis, Bleeding and Clotting Disorders, Acute Ischemic Stroke and Others, etc. Thrombosis provides greatest supports to the Coagulation Factor XI industry development. In 2022, global % share of Coagulation Factor XI went into Thrombosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Coagulation Factor XI market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Segment by Type
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Coagulation Factor XI market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Coagulation Factor XI introduction, etc. Coagulation Factor XI Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Coagulation Factor XI market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Coagulation Factor XI industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Coagulation Factor XI key companies include Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc. and LegoChem Biosciences, Inc, etc. Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC are top 3 players and held % share in total in 2022.
Coagulation Factor XI can be divided into MR-1007, IONIS-FXIRx, EP-7041 and AB-022, etc. MR-1007 is the mainstream product in the market, accounting for % share globally in 2022.
Coagulation Factor XI is widely used in various fields, such as Thrombosis, Bleeding and Clotting Disorders, Acute Ischemic Stroke and Others, etc. Thrombosis provides greatest supports to the Coagulation Factor XI industry development. In 2022, global % share of Coagulation Factor XI went into Thrombosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Coagulation Factor XI market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Segment by Type
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Segment by Application
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Coagulation Factor XI market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Coagulation Factor XI introduction, etc. Coagulation Factor XI Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Coagulation Factor XI market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.